Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 10:06 am Sale |
2023-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
Point72 Asset Management, L.P. | 493,400 0.900% |
-3,021,956 (-85.96%) |
Filing History |
| 2024-02-14 10:06 am Sale |
2023-12-31 | 13G | GRITSTONE BIO INC GRTSQ |
Point72 Asset Management, L.P. | 3,974,873 4.200% |
-3,727,958 (-48.40%) |
Filing History |
| 2024-02-14 10:04 am Sale |
2023-12-31 | 13G | FibroGen, Inc. FGEN |
Point72 Asset Management, L.P. | 65,754 1.700% |
-185,512 (-73.83%) |
Filing History |
| 2024-02-14 10:03 am Sale |
2023-12-31 | 13G | Eos Energy Enterprises, Inc. EOSE |
Point72 Asset Management, L.P. | 3,840,704 2.000% |
-1,694,326 (-30.61%) |
Filing History |
| 2024-02-14 10:02 am Sale |
2023-12-31 | 13G | Cidara Therapeutics, Inc. CDTX |
Point72 Asset Management, L.P. | 62,511 1.400% |
-130,889 (-67.68%) |
Filing History |
| 2024-02-14 10:02 am Purchase |
2023-12-31 | 13G | Avalo Therapeutics, Inc. AVTX |
Point72 Asset Management, L.P. | 2,500 0.300% |
2,500 (New Position) |
Filing History |
| 2024-02-14 10:01 am Sale |
2023-12-31 | 13G | AnaptysBio, Inc. ANAB |
Point72 Asset Management, L.P. | 788,545 3.000% |
-1,335,655 (-62.88%) |
Filing History |
| 2024-02-14 08:56 am Sale |
2023-12-31 | 13G | VistaGen Therapeutics, Inc. VTGN |
Point72 Asset Management, L.P. | 822,334 3.000% |
-743,495 (-47.48%) |
Filing History |
| 2024-02-14 07:16 am Purchase |
2023-12-31 | 13G | FARFETCH LTD FTCHQ |
Point72 Asset Management, L.P. | 20,383,303 5.800% |
1,617,894 (+8.62%) |
Filing History |
| 2024-02-14 07:15 am Sale |
2023-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX |
Point72 Asset Management, L.P. | 2,613,453 4.500% |
-572,624 (-17.97%) |
Filing History |
| 2024-02-14 07:15 am Sale |
2023-12-31 | 13G | Amylyx Pharmaceuticals, Inc. AMLX |
Point72 Asset Management, L.P. | 3,202,381 4.700% |
-268,310 (-7.73%) |
Filing History |
| 2024-02-14 07:01 am Purchase |
2023-12-31 | 13G | Semtech Corporation SMTC |
Point72 Asset Management, L.P. | 1,684,160 2.600% |
1,684,160 (New Position) |
Filing History |
| 2024-02-14 07:01 am Sale |
2023-12-31 | 13G | Syndax Pharmaceuticals, Inc. SNDX |
Point72 Asset Management, L.P. | 2,834,499 3.300% |
-685,903 (-19.48%) |
Filing History |
| 2024-02-14 07:00 am Sale |
2023-12-31 | 13G | Biohaven Ltd. BHVN |
Point72 Asset Management, L.P. | 2,552,822 3.200% |
-1,508,521 (-37.14%) |
Filing History |
| 2024-02-14 06:45 am Sale |
2023-12-31 | 13G | Bionomics Limited BNOX |
Point72 Asset Management, L.P. | 4,965,000 4.000% |
-4,959,390 (-49.97%) |
Filing History |
| 2024-02-14 06:45 am Sale |
2023-12-31 | 13G | Rapid7, Inc. RPD |
Point72 Asset Management, L.P. | 1,877,611 3.100% |
-1,214,659 (-39.28%) |
Filing History |
| 2024-02-14 06:30 am Sale |
2023-12-31 | 13G | Caribou Biosciences, Inc. CRBU |
Point72 Asset Management, L.P. | 3,997,545 4.500% |
-87,999 (-2.15%) |
Filing History |
| 2024-02-14 06:30 am Sale |
2023-12-31 | 13G | Chewy, Inc. CHWY |
Point72 Asset Management, L.P. | 1,591,442 1.300% |
-5,114,441 (-76.27%) |
Filing History |
| 2024-02-14 06:29 am Sale |
2023-12-31 | 13G | Inari Medical, Inc. NARI |
Point72 Asset Management, L.P. | 1,175,150 2.000% |
-1,620,202 (-57.96%) |
Filing History |
| 2024-02-14 06:17 am Sale |
2023-12-31 | 13G | Pulmonx Corporation LUNG |
Point72 Asset Management, L.P. | 1,546,089 4.000% |
-425,721 (-21.59%) |
Filing History |